2017
DOI: 10.3390/toxins9120386
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Abrin Holotoxin Using Novel Monoclonal Antibodies

Abstract: Abrin, a member of the ribosome-inactivating protein family, is produced by the Abrus precatorius plant. Having the potential to pose a severe threat to both human and animal health, abrin is classified as a Select Agent by the U.S. Department of Health and Human Services. However, an immunoassay that is specific for intact abrin holotoxin has not yet been reported. In this study, seven new monoclonal antibodies (mAbs), designated as Abrin-1 through Abrin-7 have been developed. Isotyping analyses indicate thes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 24 publications
0
12
0
Order By: Relevance
“…Over the last decade, several anti-abrin monoclonal antibodies (mABs) were isolated, several targeting ATA and only one targeting ATB. The mABs were found to be specific and were successfully implemented in several formats of toxin detection [ 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. The effectiveness of anti-abrin mABs neutralization in vivo was demonstrated only in two cases, where the antibodies were given as a prophylactic treatment [ 6 , 8 ], thus highlighting the need for potent anti-abrin antibodies that will provide effective post-exposure therapy.…”
Section: Introductionmentioning
confidence: 99%
“…Over the last decade, several anti-abrin monoclonal antibodies (mABs) were isolated, several targeting ATA and only one targeting ATB. The mABs were found to be specific and were successfully implemented in several formats of toxin detection [ 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. The effectiveness of anti-abrin mABs neutralization in vivo was demonstrated only in two cases, where the antibodies were given as a prophylactic treatment [ 6 , 8 ], thus highlighting the need for potent anti-abrin antibodies that will provide effective post-exposure therapy.…”
Section: Introductionmentioning
confidence: 99%
“…Regarding assay sensitivity, the two stationary ELISAs developed in this work delivered excellent detection limits: for the abrin-specific ELISA, an LOD of 22 pg/mL, and for the APA-specific ELISA, an LOD of ~35 pg/mL were determined. In comparison, previously reported ELISAs for abrin delivered detection limits between 100 pg/mL and 7800 pg/mL [ 31 , 32 , 33 , 34 , 57 ]; therefore, the current work significantly advances the field, offering tools with higher sensitivity as well as increased specificity and selectivity.…”
Section: Discussionmentioning
confidence: 92%
“…It is worthy of note that by combining a capture mAb directed against the B-chain of abrin (AP430) with a detection mAb recognizing the A-chain (AP3202), the abrin-specific ELISA detected only the intact A-B toxin. In previous works, the issue of mAb / ELISA selectivity for abrin versus APA has rarely been addressed; only a few groups have reported either cross-reactive or specific mAbs for abrin and APA derived from mouse or llama [ 32 , 56 , 57 ]. In a broader context, sandwich ELISAs able to differentiate between related toxin subtypes or isolectins have been successfully established based on highly specific mAbs directed against unique domains found in the related molecules (e.g., for ricin/RCA120 or for the related botulinum neurotoxins BoNT/C, CD, DC, and D [ 47 , 48 ]).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the cells’ cytosol, chain A cleaves the C-N bond in adenines, located in the small subunit of the ribosome 28S rRNA at the position A4324. Adenine depurination destabilizes the rRNA preventing the binding of ribosomes to elongation factors, and this results in inhibition of protein synthesis [ 90 ].…”
Section: Introductionmentioning
confidence: 99%